Literature DB >> 27683235

Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia.

Randall J Cohrs1,2, Hussain Badani3, Nicholas L Baird3, Teresa M White3, Bridget Sanford3, Don Gilden3,4.   

Abstract

Varicella zoster virus (VZV), a human neurotropic alphaherpesvirus, becomes latent after primary infection and reactivates to produce zoster. To study VZV latency and reactivation, human trigeminal ganglia removed within 24 h after death were mechanically dissociated, randomly distributed into six-well tissue culture plates and incubated with reagents to inactivate nerve growth factor (NGF) or phosphoinositide 3-kinase (PI3-kinase) pathways. At 5 days, VZV DNA increased in control and PI3-kinase inhibitor-treated cultures to the same extent, but was significantly more abundant in anti-NGF-treated cultures (p = 0.001). Overall, VZV DNA replication is regulated in part by an NGF pathway that is PI3-kinase-independent.

Entities:  

Keywords:  Human; Latency; Nerve growth factor; Phosphoinositide-3-kinase; Trigeminal ganglion; VZV

Mesh:

Substances:

Year:  2016        PMID: 27683235      PMCID: PMC5464606          DOI: 10.1007/s13365-016-0480-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  52 in total

1.  Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death.

Authors:  Werner J D Ouwendijk; Alexander Choe; Maria A Nagel; Don Gilden; Albert D M E Osterhaus; Randall J Cohrs; Georges M G M Verjans
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal Ganglia.

Authors:  Randall J Cohrs; James J Laguardia; Donald Gilden
Journal:  Virus Genes       Date:  2005-10       Impact factor: 2.332

5.  Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity.

Authors:  Heather E Eaton; Holly A Saffran; Frederick W Wu; Kevin Quach; James R Smiley
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

Review 6.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

Review 7.  The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Authors:  Israel Steiner; Peter G E Kennedy; Andrew R Pachner
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

8.  Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans.

Authors:  J G Stevens; L Haarr; D D Porter; M L Cook; E K Wagner
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

9.  Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry.

Authors:  Vaibhav Tiwari; Deepak Shukla
Journal:  J Gen Virol       Date:  2010-09-01       Impact factor: 3.891

10.  An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.

Authors:  Amos Markus; Ilana Lebenthal-Loinger; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS Pathog       Date:  2015-06-04       Impact factor: 6.823

View more
  4 in total

Review 1.  Molecular Aspects of Varicella-Zoster Virus Latency.

Authors:  Daniel P Depledge; Tomohiko Sadaoka; Werner J D Ouwendijk
Journal:  Viruses       Date:  2018-06-28       Impact factor: 5.048

Review 2.  Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.

Authors:  Nicholas L Baird; Shuyong Zhu; Catherine M Pearce; Abel Viejo-Borbolla
Journal:  Viruses       Date:  2019-01-26       Impact factor: 5.048

Review 3.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

4.  Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.

Authors:  Betty W Wu; Michael B Yee; Ronald S Goldstein; Paul R Kinchington
Journal:  Viruses       Date:  2022-02-12       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.